Profil
Ingrid Goldberg is currently Vice President-Investor Relations at Medtronic Plc since 2025.
Former roles include Director-Investor Relations at ABIOMED, Inc. from 2014 to 2019, Vice President-Investor Relations at bluebird bio, Inc. from 2020 to 2021, and Vice President-Finance & Investor Relations at NovoCure Ltd. Education includes undergraduate studies at Princeton University and an MBA from MIT Sloan School of Management.
Postes actifs de Ingrid Goldberg
| Sociétés | Poste | Début |
|---|---|---|
| MEDTRONIC PLC | Investor Relations Contact | 08/12/2025 |
Anciens postes connus de Ingrid Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Investor Relations Contact | 01/06/2021 |
| ABIOMED, INC. | Investor Relations Contact | 01/12/2019 |
| NOVOCURE LIMITED | Investor Relations Contact | - |
Formation de Ingrid Goldberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
















